Invenomic Capital Management LP Inogen Inc Transaction History

Invenomic Capital Management LP

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$5.14 - $11.28 $202,572 - $444,556	-39,411 Reduced 10.39%	339,843 $1.77 Million
Q2 2023 Aug 14, 2023	SELL	$10.01 - $13.86 $1.41 Million - $1.96 Million	-141,098 Reduced 27.12%	379,254 $4.38 Million
Q1 2023 May 15, 2023	BUY	$11.88 - $26.0 $1.66 Million - $3.64 Million	140,098 Added 36.84%	520,352 $6.49 Million
Q4 2022 Feb 14, 2023	BUY	$19.14 - $24.55 $1.28 Million - $1.65 Million	67,083 Added 21.42%	380,254 $7.49 Million
Q3 2022 Nov 14, 2022	SELL	$22.74 - $31.8 $6.67 Million - $9.33 Million	-293,351 Reduced 48.37%	313,171 $7.6 Million
Q2 2022 Aug 15, 2022	BUY	$22.88 - $35.28 $4.91 Million - $7.58 Million	214,758 Added 54.82%	606,522 $14.7 Million
Q1 2022 May 16, 2022	BUY	$28.1 - $35.25 $6.36 Million - $7.98 Million	226,338 Added 136.82%	391,764 $10.1 Million
Q4 2021 Feb 11, 2022	BUY	$29.66 - $44.0 $4.91 Million - $7.28 Million	165,426 New	165,426 $5.62 Million
Q1 2021 May 13, 2021	SELL	$43.96 - $55.99 $490,857 - $625,184	-11,166 Closed	0 $0
Q4 2020 Feb 17, 2021	BUY	$27.19 - $44.68 $103,104 - $169,426	3,792 Added 51.42%	11,166 $499,000
Q3 2020 Nov 13, 2020	BUY	$27.01 - $37.31 $199,171 - $275,123	7,374 New	7,374 $214,000

143

21M

119K

149K

Ticker INGN
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 22,866,500
Market Cap $216M
Description
Inogen, Inc., a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respirat...

Get notified when there are updates to the investment portfolio of Invenomic Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Invenomic Capital Management LP with notifications on news.